Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Hoenig

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Blood|February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment optionsMichael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2010
Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitisLena F Schimke, Julie Sawalle-Belohradsky, Joachim Roesler, et al.
Blood|June 1, 2017
Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in <i>thrombopoietin</i>Aaron Seo, Miri Ben-Harosh, Mehtap Sirin, et al.
Nature Communications|February 27, 2020
Human FCHO1 deficiency reveals role for clathrin-mediated endocytosis in development and function of T cellsMarcin Łyszkiewicz, Natalia Ziętara, Laura Frey, et al.
Nature Communications|April 22, 2020
Author Correction: Human FCHO1 deficiency reveals role for clathrin-mediated endocytosis in development and function of T cellsMarcin Łyszkiewicz, Natalia Ziętara, Laura Frey, et al.
Blood|October 23, 2013
SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCIDCatharina Schuetz, Benedicte Neven, Christopher C Dvorak, et al.
Frontiers in Immunology|May 20, 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft FailureVerena Keitel, Johannes Georg Bode, Torsten Feldt, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?Andrew R Gennery, Mary A Slatter, Laure Grandin, et al.
The Journal of Experimental Medicine|November 14, 2023
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammationVictor G Lui, Manfred Hoenig, Berenice Cabrera-Martinez, et al.
Blood Advances|November 26, 2019
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AMLBérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Blood|February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment optionsMichael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2010
Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitisLena F Schimke, Julie Sawalle-Belohradsky, Joachim Roesler, et al.
Blood|June 1, 2017
Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in <i>thrombopoietin</i>Aaron Seo, Miri Ben-Harosh, Mehtap Sirin, et al.
Nature Communications|February 27, 2020
Human FCHO1 deficiency reveals role for clathrin-mediated endocytosis in development and function of T cellsMarcin Łyszkiewicz, Natalia Ziętara, Laura Frey, et al.
Nature Communications|April 22, 2020
Author Correction: Human FCHO1 deficiency reveals role for clathrin-mediated endocytosis in development and function of T cellsMarcin Łyszkiewicz, Natalia Ziętara, Laura Frey, et al.
Blood|October 23, 2013
SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCIDCatharina Schuetz, Benedicte Neven, Christopher C Dvorak, et al.
Frontiers in Immunology|May 20, 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft FailureVerena Keitel, Johannes Georg Bode, Torsten Feldt, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?Andrew R Gennery, Mary A Slatter, Laure Grandin, et al.
The Journal of Experimental Medicine|November 14, 2023
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammationVictor G Lui, Manfred Hoenig, Berenice Cabrera-Martinez, et al.
Blood Advances|November 26, 2019
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AMLBérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, et al.
Pageof 5